[2P-0870] Proton pump inhibitors enhance Cisplatin-sensitivity in hepatocellular carcinoma cell lines

〇Naoko Yamagishi¹, Yuta Yamamoto¹, Toshio Nishi¹, Takao Ito¹, Takahi Ueyama¹ (1.Dept. of Anat., Wakayama Med. Univ.)

ConBio2017

[2P-0871] M-CSF suppresses IFN-γ secretion in splenocytes of tumor-bearing mice

〇Jing Gong¹, Kamita Kibunja Moses¹, Mitsuru Shindo^1,2, Arihiro Kano^1,2 (1.Dept. of Mol.& Mater. Sci., IGSES, Kyushu Univ, 2.Inst. for Mater. Chem. & Eng., Kyushu Univ)

ConBio2017

[2P-0872] Epigenetic Heterogeneity in Triple-negative Breast Cancer

〇Kohei Kumegawa¹, Liying Yang¹, Reo Maruyama¹ (1.Project for Cancer Epigenomics, Cancer Institute, Japanese Foundation for Cancer Research)

ConBio2017

[2P-0873] Early epigenetic alterations of peripheral blood lymphocytes of HIV-positive individuals before the lymphomagenesis

〇Akihiro Matsunaga¹, Masako Oka^1,2, Yasuaki Yanagawa³, Tomiteru Togano⁴, Kenichi Imadome⁵, Hiroyuki Gatanaga³, Shinichi Oka³, Shotaro Hagiwara^4,6, Yukihito Ishizaka¹, Mari Shimura¹ (1.Dept.of Intractable Diseases, National Center for Global Health and Medicine (NCGM), 2.Dept. of Disease Control, NCGM, 3.ADIS Clinical. Center, NCGM, 4.Div. of Hametology, NCGM, 5.Div. of Adv. Medicine for Virus Infect., National Center for Child Helath and Development, 6.Div. of Hematology, Tokyo Women's Medical Univ. )

ConBio2017

[2P-0874] Prediction of the drug sensitivity for gefitinib by in silico simulation analysis

〇Aki Sugano^1,2, Yutaka Nakamura³, Mika Ohta^1,2, Toshiyuki Sakaeda⁴, Yutaka Takaoka^1,2 (1.Div. of. Med. & Bioinfo., Kobe Univ. Hosp., 2.Life Sci. Res., Kobe Tokiwa Univ., 3.Dept. Allergy, Iwate Med. Univ., 4.Dept. of Pharmacokin., Kyoto Pharm. Univ.)

ConBio2017

[2P-0875] MyD88-activated form induces oncogenesis via NFκB-HIF1α

〇Atsuko Tanimura¹, Akane Nakazato¹, Nobuyuki Tanaka¹ (1.Dept. of Mol. Oncol., Inst. for Adv. Med. Sci., Nippon Med. Sch.)

ConBio2017

[2P-0876] Expression of phospholipase A2 and transcription factor C/EBPβ in liver macrophages from rats treated with non-genotoxic carcinogens

〇Takeshi Shimizu¹, Naoki Nanashima², Toshiyuki Yamada^1,3, Shigeki Tsuchida^1,4 (1.Dept. Biochem. Genome Biol., Hirosaki Univ. Grad. Sch. Med., 2.Dept. Biosci. Lab. Med., Hirosaki Univ. Grad. Sch. Health Sci., 3.Dept. Microbiol. Mol. Cell Biol., Nihon Pharm. Univ., 4.Dept. Rehab. Sci., Hirosaki Univ. Health Welf.)

ConBio2017

[2P-0877] Role of Mutant p53 in Regulation of Malignant Transformation of Breast Cancer Via SREBP-dependent Cholesterol Synthetic Pathway

〇Akitoshi Nakayama ¹, Sawako Suzuki¹, Seiichiro Higuchi², Mizuho Oda³, Masaki Matsumoto³, Koutaro Yokote¹, Tomoaki Tanaka² (1.Dep. of Clin. Cell Biol. and Med., Chiba Univ. Sch. of Med., 2.Dep. of Mol. Diag. Div. of Clin. Gene. and Proteo., Chiba Univ. Sch. of Med., 3.Res. Ctr. transo. Med. Div. Proteo., Med.Inst. Bioreg., Kyushu Univ.)

ConBio2017

[2P-0878] EZH2 overexpression through IKK-ε－NF-κB pathway in colorectal cancers

〇Keiko Shinjo¹, Natsuki Dohi², Akira Hatanaka², Keisuke Katsushima¹, Yutaka Kondo¹ (1.Div. Cancer Biol., Nagoya Univ. Grad. Sch.of Med., 2.Dep. of Epigenomics, Nagoya City Univ. Grad. Sch. of Med. Sci.)

ConBio2017

[2P-0879] Development of a Patient Derived pancreatic cancer organoid recapitulating the tumor microenvironment

〇Ryo Okuda¹, Keisuke Sekine¹, Yasuharu Ueno¹, Tatsuya Inoue¹, Chinatsu Kaneko¹, Ayaka Usui¹, Hideki Taniguchi¹ (1.Dept. of Regenerative. Med., Univ. of Yokohama city)

ConBio2017